Catalyst Wire Dossier Catalyst Wire Dossier

Myalepta

metreleptin
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Myalepta, covering 2025-11-03 to 2026-03-24. Get the full timeline:

Most recent: Clinical Trial Update: Compassionate Use of Metreleptin in Previously Treated People With Generalized Lipodystrophy [Phase 3]

See pricing